Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Journal of Translational Medicine
|
July 23, 2024
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer
Chiara Papulino, Ugo Chianese, Ahmad Ali, et al.
Journal of Medicinal Chemistry
|
December 12, 2013
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities
Dante Rotili, Stefano Tomassi, Mariarosaria Conte, et al.
Cancer Research
|
February 26, 2014
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392
Floriana De Bellis, Vincenzo Carafa, Mariarosaria Conte, et al.
ACS Medicinal Chemistry Letters
|
September 19, 2019
Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease"
Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
ACS Medicinal Chemistry Letters
|
April 19, 2019
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease
Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
The International Journal of Biochemistry & Cell Biology
|
July 16, 2024
Corrigendum to "Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities" [Int. J. Biochem. Cell Biol. 39(10) (2007) 1902-1914]
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
The International Journal of Biochemistry & Cell Biology
|
July 3, 2007
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
Oncogene
|
September 13, 2025
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis
Guglielmo Bove, Mehrad Babaei, Alberto Bueno-Costa, et al.
Journal of Translational Medicine
|
June 23, 2009
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells
Paola Bontempo, Luigi Mita, Antonella Doto, et al.
European Journal of Medicinal Chemistry
|
November 19, 2018
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents
Margherita Brindisi, Cristina Ulivieri, Gloria Alfano, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Journal of Translational Medicine
|
July 23, 2024
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer
Chiara Papulino, Ugo Chianese, Ahmad Ali, et al.
Journal of Medicinal Chemistry
|
December 12, 2013
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities
Dante Rotili, Stefano Tomassi, Mariarosaria Conte, et al.
Cancer Research
|
February 26, 2014
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392
Floriana De Bellis, Vincenzo Carafa, Mariarosaria Conte, et al.
ACS Medicinal Chemistry Letters
|
September 19, 2019
Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease"
Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
ACS Medicinal Chemistry Letters
|
April 19, 2019
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease
Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
The International Journal of Biochemistry & Cell Biology
|
July 16, 2024
Corrigendum to "Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities" [Int. J. Biochem. Cell Biol. 39(10) (2007) 1902-1914]
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
The International Journal of Biochemistry & Cell Biology
|
July 3, 2007
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
Oncogene
|
September 13, 2025
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis
Guglielmo Bove, Mehrad Babaei, Alberto Bueno-Costa, et al.
Journal of Translational Medicine
|
June 23, 2009
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells
Paola Bontempo, Luigi Mita, Antonella Doto, et al.
European Journal of Medicinal Chemistry
|
November 19, 2018
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents
Margherita Brindisi, Cristina Ulivieri, Gloria Alfano, et al.
Page
of 7